272 related articles for article (PubMed ID: 25769577)
1. Incidence of contrast-induced nephropathy in kidney transplant recipients.
Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
[TBL] [Abstract][Full Text] [Related]
2. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
4. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
5. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
6. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
7. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
[TBL] [Abstract][Full Text] [Related]
8. An uninvestigated risk factor for contrast-induced nephropathy in chronic kidney disease: proteinuria.
Piskinpasa S; Altun B; Akoglu H; Yildirim T; Agbaht K; Yilmaz R; Peynircioglu B; Cil B; Aytemir K; Turgan C
Ren Fail; 2013; 35(1):62-5. PubMed ID: 23176376
[TBL] [Abstract][Full Text] [Related]
9. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
10. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
11. Contrast-induced acute kidney injury in renal transplant recipients after cardiac catheterization.
Agrawal V; Swami A; Kosuri R; Alsabbagh M; Agarwal M; Samarapungavan D; Rocher LL; McCullough PA
Clin Nephrol; 2009 Jun; 71(6):687-96. PubMed ID: 19473638
[TBL] [Abstract][Full Text] [Related]
12. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
[No Abstract] [Full Text] [Related]
13. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.
Fukushima Y; Miyazawa H; Nakamura J; Taketomi-Takahashi A; Suto T; Tsushima Y
Jpn J Radiol; 2017 Aug; 35(8):427-431. PubMed ID: 28528465
[TBL] [Abstract][Full Text] [Related]
15. Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography.
Lee JH; Chung B; Lee SC; Kim SS; Koh HJ; Lee CS
BMC Ophthalmol; 2017 Apr; 17(1):46. PubMed ID: 28420348
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
17. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
18. Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial.
Kiski D; Stepper W; Breithardt G; Reinecke H
J Womens Health (Larchmt); 2010 Jul; 19(7):1363-8. PubMed ID: 20545479
[TBL] [Abstract][Full Text] [Related]
19. Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department?
De Simone B; Ansaloni L; Sartelli M; Gaiani F; Leandro G; De' Angelis GL; Di Mario F; Coccolini F; Catena F
Acta Biomed; 2018 Dec; 89(9-S):158-172. PubMed ID: 30561410
[TBL] [Abstract][Full Text] [Related]
20. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
